Aptive Secures New Contract to Support VA’s National Cancer Registry Services

The Veterans Affairs Central Cancer Registry System (VACRS) consolidates cancer diagnosis, treatment and outcomes data from more than 130 VA Medical Centers into a centralized database. This data is critical for clinical decision-making, public health planning and cancer research, helping identify trends, improve survival rates and ensure quality in cancer care for Veterans.

“We look forward to partnering with VA to expand cancer data sharing with the National Cancer Institute, linking the registry with Defense Health Agency, increasing genomic data collection and analysis and integrating cancer data with VA’s electronic health record system to drive improved cancer outcomes for Veterans and all citizens,” said Sean Lenehan, Aptive’s Chief Operating Officer.

Through this award, Aptive will support 84 VA Medical Centers by helping address a backlog of nearly 28,000 cases and delivering comprehensive registry services for an estimated 57,821 cases in the first year. The effort will provide specialized technology enabled oncology data specialists who improve and accelerate the accuracy, timeliness and quality of cancer data, while also supporting compliance with national standards from the CDC, the American College of Surgeons and the National Cancer Institute.

“This contract underscores Aptive’s commitment to advancing Veteran health outcomes,” said Sean Lenehan. “By enhancing cancer data collection and analysis, we’re helping VA clinicians and researchers make more informed decisions, ultimately improving prevention, treatment and quality of life for Veterans with cancer.”

This project represents a critical step in expanding VHA’s ability to monitor cancer incidence, support clinical trials and strengthen both immediate patient care and long-term research initiatives.